| The therapeutic monoclonal antibody market | 2015/01/02 | English | 876 |
| The making of bispecific antibodies | 2017/01/10 | English | 570 |
| The immunogenicity of humanized and fully human antibodies | 2010/05/01 | English | 445 |
| Cell culture processes for monoclonal antibody production | 2010/09/01 | English | 433 |
| Industrialization of mAb production technology: The bioprocessing industry at a crossroads | 2009/09/01 | English | 424 |
| Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma | 2015/03/04 | English | 372 |
| Recovery and purification process development for monoclonal antibody production | 2010/09/01 | English | 339 |
| Antibodies to watch in 2020 | 2019/12/26 | English | 329 |
| Antibodies to watch in 2019 | 2018/12/22 | English | 326 |
| Charge variants in IgG1 | 2010/11/01 | English | 314 |
| Antibody fragments | 2010/01/01 | English | 298 |
| Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates | 2016/04/05 | English | 295 |
| Dual targeting strategies with bispecific antibodies | 2012/03/01 | English | 295 |
| Disulfide bond structures of IgG molecules | 2012/01/01 | English | 293 |
| Marketed therapeutic antibodies compendium | 2012/05/01 | English | 272 |
| Analytical methods for physicochemical characterization of antibody drug conjugates | 2011/03/01 | English | 247 |
| Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties | 2013/01/01 | English | 238 |
| Discovery and mechanism of ustekinumab | 2011/11/01 | English | 223 |
| Bispecific antibodies for cancer therapy | 2009/11/01 | English | 217 |
| Fragmentation of monoclonal antibodies | 2011/05/01 | English | 216 |
| Antibodies to watch in 2022 | 2022/01/14 | English | 210 |
| Phage display-derived human antibodies in clinical development and therapy | 2016/08/15 | English | 208 |
| Antibodies to watch in 2021 | 2021/01/01 | English | 208 |
| Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies | 2012/09/01 | English | 204 |
| The impact of glycosylation on monoclonal antibody conformation and stability | 2011/11/01 | English | 201 |
| Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data | 2011/01/01 | English | 198 |
| Macrophages are critical effectors of antibody therapies for cancer | 2015/02/10 | English | 195 |
| Antibodies to watch in 2017 | 2016/12/14 | English | 193 |
| Antibodies to watch in 2018 | 2018/01/16 | English | 191 |
| The “less-is-more” in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity | 2018/05/07 | English | 190 |